WebRelease time:2024-08-09. Recently, China National Intellectual Property Administration announced the decision of the 23rd China Patent Award, and the compound patent of Anlotinib, a new class 1 drug in the field of anti-tumor of Sino Biopharm CTTQ, "Spiro-substituted compounds as angiogenesis inhibitors" (Patent No. ZL200880007358.X), … WebSep 19, 2024 · Nokia recently signed deals with larger phone makers Samsung Electronics and Apple, as well as China’s Xiaomi Technology. Nokia’s patent unit had sales of 616 million euros (N$10 billion) in ...
The 22nd China Patent Award list was …
http://www.mcc.com.cn/mccen/about_mcc/about_mcc60/index.html WebJun 13, 2024 · Chinese Invention Patent Grants Up 63% in May 2024 YoY. Sunday, June 13, 2024. The China National Intellectual Property Administration (CNIPA) recently … dave grohl the story teller
Congratulations to BPI for winning the "China Patent Excellence …
WebJun 15, 2024 · The China patent award is divided into gold award, silver award and Excellence Award. It is a national level patent selection activity. The 21st China patent … WebSince 2009, it has won the China Patent Award 52 times (winning the China Patent Gold Award for 3 consecutive years from 2015 to 2024). Since 2000, it has won the National … WebEndostar inhibits tumor growth by its antiangiogenic effect, and has won the Second Prize of National Scientific and Technological Progress Award, and China Patent Gold Award. Endostar ® has been included in the NRDL since 2024 and is recommended as a first-line treatment for patients with advanced non-small-cell lung carcinoma (NSCLC) by a ... black and grey nike tech tracksuit